# Richard Schilsky
Top Podcast-Folgen
Aktualisiert:
Top podcast episodes featuring richard schilsky.
The 2013 Top Five List in Oncology: What This Means for Patients, with ASCO CMO Richard Schilsky, MD
In this podcast, Dr. Richard Schilsky, an oncologist and the Chief Medical Officer of ASCO, provides an overview of ASCO’s second Top Five List in Oncology, issued in October 2013.
Cancer Basics
2011 ASCO Annual Meeting Highlights on Personalized Medicine and Childhood Leukemia, with Richard Schilsky, MD
In this podcast, we discuss news highlighted at ASCO's 2011 Annual Meeting regarding personalized medicine and childhood leukemia.
Cancer Research News
Next generation of trials with targeted agents
Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
Dr Richard Schilsky, Chief Medical Officer of the American Society of Oncology (ASCO) and chairman of the WIN Consortium Scientific Advisory Board, provides ecancertv with an overview of a roundtable session h…
What is the TAPUR (Targeted Agent and Profiling Utilization Registry) Study, with Richard Schilsky, MD, FACP, FASCO
ASCO’s first clinical trial is the Targeted Agent and Profiling Utilization Registry, or TAPUR Study. This clinical trial is intended for people with advanced cancer without other treatment options available, and whose cancer has at least one genomic variation that can be targeted with specific …
S09 E01 Tumor-Agnostic Therapies: Is The TAPUR Study Right For You?
Send us Fan Mail
For our Season 9 opening episode, we're learning about agnostic treatments in cancer with Dr. Richard Schilsky of ASCO, who discusses the TAPUR Study. You may wonder, what is TAPUR and how does it relate to agnostictreatments? The pioneer behind the study, Dr. Schilsky, explains c…
Pembrolizumab in Patients With Advanced Cancers With HTMB
Dr. Shannon Westin and her guests, Dr. Herbert Duvivier and Dr. Richard Schilsky, discuss the paper "Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study" published in the JCO.
TRANSCRIPT
The guest on …
What is the TAPUR (Targeted Agent and Profiling Utilization Registry) Study, with Richard Schilsky, MD, FACP, FASCO
ASCO: You're listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the voice of the world's oncology professionals.
The purpose of this podcast is to educate and to inform. This is not a substitute for profe…
A Decade of Data: JCO PO and the TAPUR Study
JCO PO Editor-in-Chief Emeritus Dr. James Ford and Founding PI, ASCO TAPUR Study, Dr. Richard Schilsky discuss the 10-year anniversary of the Targeted Agent and Profiling Utilization Registry (TAPUR)™ Study and its relationship with the journal. Host Dr. Rafeh Naqash and guests discuss the inceptio…
PODCAST-SUCHMASCHINE
Auf unserer Website können Sie3,833,765-Podcasts und197,120,913-Folgen nach Personen, Orten oder Themen durchsuchen.
Eine Investition in Wissen bringt die besten Zinsen – deshalb höre ich Podcasts.
‐ Benjamin "Llamacorn" Franklin
BEARBEITEN
Vielen Dank, dass Sie uns helfen, die Podcast-Datenbank auf dem neuesten Stand zu halten.
